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P hosphoinositide 3-kinases (PI3Ks) are a family of enzymes characterized by protein and lipid kinase activity. Class IA PI3Ks (PI3K␣, -␤, and -␦) are mainly activated downstream tyrosine kinase receptors, whereas the single member of class I B PI3Ks, PI3K␥, is activated on stimulation of G protein-coupled receptors (GPCRs) and is regulated by free G ␤␥ subunits of heterotrimeric G proteins. PI3Ks catalytic activity leads to the accumulation of phosphatidylinositol-3,4,5-tris-phosphate in the plasma membrane, which acts as docking site for pleckstrin homology domain containing effectors, including protein kinase B (PKB/Akt). 1 The signaling pathway downstream of activated Akt controls cell-cycle progression, cell survival, growth, metabolism and movement. 2 The contribution of class IA PI3K isoforms to angiogenic processes has been thoroughly dissected. 3 In contrast, the involvement of PI3K␥ in reparative angiogenesis is not firmly established. Seminal studies showed that PI3K␥ is expressed not only in hematopoietic cells but also in endothelial cells (ECs) and cardiomyocytes, 4 and acts as a modulator of leukocyte-EC interaction at inflammation sites, through the control of E-selectin-mediated adhesion. 5 Moreover, PI3K␥ has been shown to be essential for Sphingosine-1-phosphate(S1P)-induced EC migration. 6 Using PI3K␥ knockout (KO) mice with unilateral limb ischemia, we and others have recently demonstrated the contribution of PI3K␥ to reparative neovascularization and endothelial progenitor cell functions. 7, 8 Interestingly, mutant mice expressing catalytically inactive PI3K␥ (kinase dead [KD] ) displayed normal angiogenesis following induction of limb ischemia. 7 Of note, substantial differences were also denoted in the cardiac phenotype of PI3K␥ mutant animals. In fact, KO but not KD mice, showed a basal enhancement of cardiac contractility and developed cardiac damage following aortic constriction. These differential effects were attributed to the fact that PI3K␥ may exert distinct functions through its kinase activity and kinase-independent scaffolding action. 9 Healing of the infarcted heart is accomplished through chemokine-mediated recruitment of inflammatory cells, differentiation of macrophages and myofibroblasts and formation of new vessels and scar tissue. We hypothesize that genetic or pharmacological inactivation of PI3K␥ might significantly interfere with this finely tuned process and thereby impact on functional recovery of the infarcted heart. To address this important question, we used AS605240 (AS), the most potent member of a new class of PI3K␥-selective inhibitors recently introduced as powerful antiinflammatory agents for treatment of rheumatoid arthritis, systemic lupus and atherosclerosis, 10 -12 as well as genetically modified animal models with disrupted or inactivated PI3K␥. Results newly demonstrate an unexpected complex contribution of PI3K␥ to reparative angiogenesis in myocardial infarction (MI).
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Cell Cultures
Human umbilical vein ECs (HUVECs) and adult mouse cardiomyocytes (HL-1 cells) were cultured according to manufacturer's instruction and as described. 13 In all in vitro experiments, culture media were supplemented with either 1 mol/L AS, 15 mol/L LY294002 (LY) (pan-class I PI3K inhibitor) in DMSO or an equal volume of DMSO alone (vehicle). AS is a potent and highly selective smallmolecule PI3K␥ inhibitor that exhibits no notable activity against a wide panel of other protein kinases at 1 mol/L. 11 Adenoviral constructs have been described previously. 14, 15 Infections were performed overnight at 100 multiplicities of infection.
In Vitro Functional Assays
Cell Proliferation 5-Bromodeoxyuridine incorporation was detected using a colorimetric 5-bromodeoxyuridine assay kit according to the instructions of the manufacturer.
Scratch Assay
HUVEC migration was evaluated by measuring the distance between migrating fronts as described. 16 In Vitro Angiogenesis Assay HUVEC angiogenic capacity was assessed in a Matrigel-based assay. Number of branches and total length of ECs networks were calculated using the Image-Pro Plus software.
Apoptosis Assay
Hypoxia/starvation-induced activation of caspase-3/7 was assessed using a luminescent detection kit according to the instructions of the manufacturer.
Animal Procedures
Experiments involving mice were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals (the Institute of Laboratory Animal Resources, 1996) and with approval of the British Home Office and the University of Bristol. Nine-week-old male CD1 mice (Harlan) received AS (10 mg/kg, IP) or DMSO (vehicle) daily from 3 days before MI until euthanasia. KD and KO mice were generated as described 9, 17 and compared with wild-type (WT) littermates.
MI was induced by permanent ligation of left anterior descending artery using a 7 to 0 silk suture. 18 Sham-operated animals underwent a similar procedure without ligation.
Cardiac function was evaluated using a mouse-dedicated echocardiography system with spatial resolution down to 30 m (Vevo 770, VisualSonics) before and on day 14 after MI or sham operation.
On day 3 or 14 post-MI, hearts were stopped in diastole by intracardiac injection of cadmium chloride and perfused/fixed and collected for histological analyses. Alternatively, left ventricles were immediately frozen with liquid nitrogen for molecular analysis.
Immunoblot Analyses
Preparation of protein extracts and immunoblot analyses were performed as described. 16 
Assessment of Akt Kinase Activity in Heart Samples
Akt activity was assessed using the Akt/PKB Kinase Activity Assay kit according to the instructions of the manufacturer.
Immunohistochemical Detection of Leukocytes
To identify infiltrating leukocytes, paraffin-embedded sections (3 m thick) were stained with an anti-CD45 monoclonal antibody. The average number of CD45-positive cells per square millimeter of tissue and per arteriole was calculated in periinfarct (PI) zone of sections from the midventricular area of AS-or DMSO-treated hearts 3 days post-MI.
(TUNEL-positive) ECs at 3 days post-MI were evaluated in PI zone of heart sections (3 m thick) from the midventricular area.
Infarct Size
Hearts were harvested at 14 days post-MI. Sections from 3 levels of each heart (apical, midventricular, and basal) were stained by Azan Mallory and analyzed by morphometry. 19 
Statistical Analysis
Results are presented as meansϮSEM. Differences between multiple groups were compared by analysis of variance (1-or 2-way ANOVA and Bonferroni post test), and differences between 2 groups were compared by paired or unpaired Student t test. PϽ0.05 was considered significant. Stated n values represent biological replicates.
Results

Inhibition or Silencing of PI3K␥ Impair Angiogenesis-Related Processes
In HUVECs, the PI3K␥ inhibitor AS dose-dependently inhibited serum-stimulated phosphorylation of Akt and its downstream substrates, glycogen synthase kinase (GSK)3␤ and endothelial nitric oxide synthase (eNOS) (Online Figure  I, A) . Overexpression of PI3K␥ by adenovirus-mediated gene transfer resulted in Akt phosphorylation, which was inhibited by AS (Online Figure I, B) . At 1 mol/L, AS showed no inhibitory activity toward vascular endothelial growth factor (VEGF)-induced activation of the PI3K/Akt pathway (Online Figure I, C) . Altogether, these data confirm selectivity of the PI3K␥ inhibitor at the cellular level.
Serum-induced proliferation of HUVECs was strongly decreased by AS and, to a greater extent, by the unselective PI3K inhibitor LY ( Figure 1A ). Moreover, both AS and LY equally affected HUVEC migration in in vitro scratch assays ( Figure 1B) . Furthermore, PI3K␥ inhibition impaired the ability of HUVECs to form networks in a Matrigel-based angiogenesis assay, as indicated by the reduced number of branches and network total length ( Figure 1C) , and increased caspase-3/7 activities following exposure of HUVECs to hypoxia and serum starvation ( Figure 1D ). Similar effects were observed in HUVECs treated with LY.
To confirm the results obtained with AS, HUVECs were transduced with an adenoviral construct expressing a small interfering (si)RNA against p110␥ (Ad.siRNA␥), PI3K␥ catalytic subunit, or scrambled control (Ad.scrambled). Ad.siRNA␥ reduced PI3K␥ protein expression effectively (greater than 75%) and selectively (no inhibitory effect on other PI3K isoforms) (Figure 2A) . Moreover, Ad.siRNA␥-transduced HUVECs showed a marked weakening in all angiogenic functions and increased apoptosis following hypoxia/starvation ( Figure 2B through 2E). AS treatment of Ad.siRNA␥-transduced ECs did not induce any further functional falloff, thus underscoring the compound specificity (Online Figure II, A through D) .
Rescue of AS-Inhibited Angiogenesis by Constitutively Active Akt
The activated Akt pathway has been shown to promote vascular cell survival and angiogenesis. 20 -22 Western blot analyses confirmed the inhibitory effect of AS and LY on serum-stimulated phosphorylation of Akt, GSK3␤ and eNOS Matrigel-based angiogenesis assay: both number of branches/view field (i) and network total length/view field (mm) (ii) were counted. D, Bar graph shows Caspase-3/7 activity assessed by measuring the luminescent signal generated by DEVD cleavage in extracts of HUVECs that were serum-starved and exposed to hypoxia (0.2% O 2 , 5% CO 2 ) in the presence of DMSO, AS, or LY for 18 hour (nϭ3 for each assay). *PϽ0.05, **PϽ0.01, ***PϽ0.001 vs DMSO; ###PϽ0.001 vs AS. Scale bars: 500 m.
( Figure 3A ). Extracellular signal-regulated kinases 1/2 (Erk1/2) are considered downstream and ultimate effectors of the mitogen-activated protein kinase (MAPK) pathway, triggered also by PI3K␥. 23, 24 Interestingly, both AS and LY caused a significant decrease of Erk1/2 phosphorylation levels ( Figure 3A, iv) . Similarly, on PI3K␥ knockdown, both the Akt and the MAPKs pathways were strongly downmodulated ( Figure 3B ).
We next asked whether restoration of the Akt pathway could rescue the angiogenic defect resulting from PI3K␥ inhibition. To this aim, HUVECs were infected with a constitutively active form of Akt (hemagglutinin-tagged myristoylated Akt; Ad.MyrAkt), thus resulting in phosphorylation of the downstream targets ( Figure 3C ). Control HUVECs were infected with an empty adenovirus (Ad.Null). In vitro endothelial network formation was impaired in Nulltransduced HUVECs treated with either AS or LY, whereas restoration of Akt activity completely rescued this defect ( Figure 3D ).
Effects of PI3K␥ Inhibition on Cell Signaling in Infarcted Hearts
We then evaluated the activation status of the PI3K␥/Akt pathway in left ventricular (LV) samples collected from ASor DMSO-treated mice 3 days post-MI or sham operation. MI induced a marked upregulation of PI3K␥ in the LV of both treatment groups, as assessed by immunoblot analysis ( Figure  4A ). By immunohistochemistry, we found that cardiomyocytes and ECs overexpressed PI3K␥ in the PI zone, whereas in sham-operated mice, PI3K␥ expression appeared rather diffuse and weak (Online Figure III) . Akt phosphorylation levels and relative catalytic activity did not differ between DMSO-and AS-treated sham-operated mice, whereas MIinduced activation of Akt was not only completely abrogated Figure 2 . Silencing of PI3K␥ impairs angiogenesis. A, HUVECs were transduced with 100 multiplicities of infection of Ad.scrambled or Ad.siRNA␥ overnight. Both adenoviral constructs carried GFP allowing straightforward assessment of infection efficiency. Top, GFP expression 3 days after infection. Bottom, Immunoblot analysis of PI3K isoforms expression in HUVECs harvested 3 days after infection. GAPDH is shown as loading control. The silencing approach does not affect PI3K␣ or PI3K␤ expression. PI3K␥ is selectively and effectively downregulated. Assays were performed as in Figure 1 , 3 days after adenoviral transduction. Three independent infections were performed for both Ad.siRNA␥ and Ad.scrambled. Results indicate that PI3K␥ is essential to cell proliferation (B), migration (C), tube-like network formation (D), and survival (E) of ECs (nϭ3 for each experiment). *PϽ0.05, **PϽ0.01, ***PϽ0.001 vs scrambled; ###PϽ0.001 vs Ad.siRNA␥. by AS but also strongly decreased below the levels of AS-treated sham-operated mice ( Figure 4B and 4C). Phosphorylation levels of GSK3␤ and eNOS followed the same trend observed for Akt ( Figure 4D and 4E). Furthermore, Pim-1, a recently reported mediator of cardiomyocyte survival, downstream of Akt, 25 was found strongly downmodulated in infarcted hearts of AS-treated mice ( Figure 4F ).
PI3K␥ Inhibition by AS or PI3K␥ Knockout Exacerbates MI-Induced Cardiac Dysfunction
In sham-operated mice, AS did not cause any significant alteration in LV function, as assessed by echocardiography (Online Table I ). However, AS significantly worsened MIinduced cardiac dysfunction compared to DMSO (Table) .
We then evaluated the impact of MI on PI3K␥ genetically modified mice. Before MI, PI3K␥ KO mice showed higher LV ejection fraction (LVE f ) and fractional shortening (LVFS) compared with KD or WT littermates (Online Table II ), in line with previous reports indicating hyper-contractility of KO hearts under basal conditions. 9, 26 However, following MI, the function of KO hearts was more severely compromised as compared with WT and KD (Online Table II 
Targeting of PI3K␥ Suppresses Post-MI Reparative Neovascularization
In DMSO-treated or WT mice, capillary density of the PI zone was higher than that of R zone. Importantly, reparative capillarization was abrogated by pharmacological inhibition ( Figure 5A and B ͓i͔) or genetic deletion (KO) or inactivation (KD) of PI3K␥ ( Figure 5B , ii).
Analysis of arteriole density unraveled a significant increase of small arterioles (diameter Ͻ50 m) in the PI zone of DMSO-treated hearts, which was abrogated by AS ( Figure  5A , 5C ͓i͔, and 5D ͓i͔). Similarly, arteriole density was reduced in KD and KO hearts as compared to WT ( Figure 5C [ii] and 5D [ii]), with the arteriole defect being more prominent in KO. We did not find any difference in the number of arterioles with diameter Ն50 m among groups, regardless the treatment received or genotype (data not shown). 
Differential Effects of AS and PI3K␥ Genetic Inactivation on EC and Cardiomyocyte Biology
The finely tuned balance between EC proliferation and apoptosis early after an ischemic injury determines the extent of the neovascularization response. 7, 16 Therefore, we analyzed hearts at 3 days post-MI to quantify the fraction of proliferating/apoptotic ECs in PI zone. Interestingly, AStreated hearts exhibited a 2-fold reduction in the percentage of proliferating ECs as compared to DMSO ( Figure 6A and 6B ͓i͔). Surprisingly, only KO hearts exhibited a similar phenotype, whereas KD hearts showed no impairment in EC proliferation ( Figure 6B , ii). Of note, EC apoptosis was remarkably increased in the PI zone of AS-treated as well as of KD and KO hearts ( Figure 7A and B [i and ii]).
PI3K␥ is also crucial for cardiomyocyte survival. In fact, apoptosis was enhanced by 2-and 2.3-fold in the PI zone of AS-treated and KD hearts ( Figure 7A and 7B [iii and iv]). Of note, cardiomyocyte apoptosis was even more activated in KO hearts ( Figure 7B, iv) . To verify the direct effect of PI3K␥ inhibition on cardiomyocytes survival, serum-starved adult mouse cardiomyocytes (HL-1) were treated with DMSO or AS and exposed to hypoxia. As shown by measurement of Caspase-3/7 activation, AS treatment enhanced cardiomyocyte apoptosis ( Figure 7C ).
PI3K␥ Is Crucial for Leukocyte Homing
Leukocytes recruited in the infarct and PI zone are of central importance for myocardial and vascular remodeling. [27] [28] [29] [30] AS strikingly reduced the number of CD45 pos leukocytes in the PI zone at 3 days post-MI as compared to DMSO (Online Figure V, A and B ͓i͔) . Further immunohistochemical studies showed that neutrophils and monocytes/macrophages are the most affected populations, although a less marked decrease in T lymphocytes recruitment was also observed (Online Figure  VI) . Importantly, leukocytes adhering to the arteriolar endothelial lining or infiltrating the arteriole wall were 13.3-fold less frequent in AS-treated hearts as compared to DMSOtreated hearts (Online Figure V, A and C ͓i͔) . Molecular analysis on protein extracts of primary monocytes/macrophages and lymphocytes isolated from the peripheral blood of infarcted mice 2 days post-MI showed a strong inhibition of the Akt pathway on AS treatment (Online Figure VII, A and  B) . Moreover, AS-treated bone marrow mononuclear cells from the same infarcted mice displayed impaired directional migratory capacity in vitro (Online Figure VII, C) .
In line with the above results, analyses performed in hearts from genetically modified mice revealed a markedly reduced leukocyte infiltration in PI zone of KD and, to a bigger extent, KO mice as compared to WT (Online Figure V, 
B [ii] and C [ii]).
Discussion
The high degree of functional specialization among members of the PI3K family combined with the recent understanding of their involvement in several human diseases has fostered the development of isoform-specific inhibitors. 31 In this context, a recent study identified PI3K␣ as a major regulator of developmental angiogenesis and VEGF-dependent EC migration. 3 Here, we present novel data supporting the concept that PI3K␥, which is primarily activated on stimulation of GPCRs, plays a crucial role in reparative angiogenesis. Inhibition of PI3K␥ catalytic activity, achieved by either a highly selective PI3K␥ inhibitor, AS, or siRNA-mediated knockdown of PI3K␥ catalytic subunit, exerts detrimental effects on EC proliferation, migration, network formation, and survival in vitro. The decisive role of PI3K␥ in controlling angiogenesis-related processes is underscored in that LY, a pan PI3K inhibitor, did not affect further any EC function but cell proliferation. Because PI3K␣ is not involved in the regulation of EC proliferation and PI3K␦ is scarcely expressed in HUVECs, 3 PI3K␤ might be responsible for the modulation of EC proliferation, together with PI3K␥. We also demonstrate that Akt is fundamental for PI3K␥-driven angiogenesis. Indeed, PI3K␥ inhibition and PI3K␥ knockdown resulted in reduced activation of Akt and eNOS, accompanied by the release of Akt inhibitory action on GSK3␤, which can therefore inhibit downstream targets required for cell cycle progression. 32 Importantly, restoration of the Akt pathway led to recovery of EC angiogenic capacity. PI3K␥ inhibition also hampered the MAPK pathway, thus contributing to the observed proliferative defect.
MI remains one of the leading causes of morbidity and mortality worldwide despite improved management of risk factors and state-of-the-art treatments. 33 In theory, inhibitors of PI3K do not represent the best candidate for the treatment of MI, considering the proangiogenic and prosurvival action exerted by the PI3K/Akt signaling pathway in myocardial ischemia. 34, 35 However, selective PI3K␥ inhibitors might have potential cardio-protective applications, especially for the treatment of atherosclerosis, 12 and under conditions of increased workload, through the reduction of leukocyte infiltration and myocardial fibrosis. 9 Whether inhibitors of PI3K␥ may beneficially impact on post-MI healing by constraining excessive inflammation and fibrosis without jeopardizing reparative angiogenesis is a matter of growing interest. The dual PI3K␥/␦ inhibitor TG100-115 has been recently tested in animal models of ischemia/reperfusion injury, where it reduced infarct size and improved myocardial function without affecting the number of inflammatory cells infiltrating the infarcted myocardium. This compound had no effect on VEGF-induced EC proliferation, angiogenesis and Erk phosphorylation, but it blocked VEGF-induced phosphorylation of Akt. 36 A puzzling aspect of the above study is that only the angiogenesis driven by VEGF, which signals through tyrosine kinase receptors, was explored, thus leaving open the possibility that the inhibitor might or might not interfere with GPCR-dependent angiogenesis. Furthermore, PI3K␥ is known to play a pivotal role in chemokine-induced migration of neutrophils, monocytes/macrophages, and T lymphocytes to hypoxic or inflamed tissues 17, [37] [38] [39] ; therefore, the lack of effects of TG100-115 on myocardial inflammation casts doubts about complete abrogation of PI3K␥ signaling in leukocytes recruited to the infarcted heart.
AS is the most representative member of a new class of PI3K␥-selective inhibitors which proved to exert therapeutic effects in murine models of chronic inflammatory/autoimmune diseases and atherosclerosis. 10 -12 In our experimental design, mice received AS before MI induction, mimicking the hypothetical clinical situation in which patients are already under treatment when MI occurs. One primary molecular hallmark of MI hearts was the striking upregulation of PI3K␥ associated to activation of Akt/eNOS and inhibition of GSK3␤. AS treatment completely suppressed the MIdependent activation of Akt and phosphorylation/expression of its downstream targets, including Pim1, an Akt-regulated enhancer of cardiomyocyte survival. 25 These molecular findings anticipate that inhibition of PI3K␥ may interfere with different cellular functions relevant to cardiac recovery.
A balanced and coordinated inflammatory response is instrumental to degradation of extracellular matrix, clearance of dead cells, and replacement of necrotic areas by connective tissue. 27, 40 Furthermore, recruited monocytes contribute to the restoration of perfusion through direct and paracrine promotion of neovascularization. 30, 40 In line with the established antiinflammatory action of PI3K␥ inhibitors, AS-treated hearts displayed a highly reduced infiltration of leukocytes and essentially no leukocytes surrounding arterioles. Importantly, we verified that AS causes a striking downregulation of Akt phosphorylation in monocytes and lymphocytes from peripheral blood of infarcted mice and remarkably reduces the migratory activity of bone marrow mononuclear cells from the same animals. After acute ischemia, the circulating monocyte fraction becomes enriched with proangiogenic progenitor cells. We have recently demonstrated that PI3K␥ is constitutively expressed in human proangiogenic progenitor cells and recruited to the cell membrane in a polarized fashion on stimulation with the GPCR ligand bradykinin. 41 Furthermore, PI3K␥-silenced human progenitor cells, as well as PI3K␥-deficient murine BM-derived proangiogenic cells exhibited remarkably depressed migratory activity, reduced Akt and eNOS phosphorylation, and decreased nitric oxide production, which jeopardize their regenerative potential. 41, 42 We then investigated the effect of AS on angiogenesis at the initial (3 days post-MI) and stabilization phase (14 days post-MI) of the healing process. Of note, AS-treated mice failed in mounting an adequate neovascularization response at capillary and arteriole level, with enhanced EC apoptosis and decreased EC proliferation accounting for such dysfunction. Similarly, cardiomyocytes were found more apoptotic in AS-treated hearts as compared to controls. A direct action of AS on cardiomyocyte survival was documented in vitro. Finally, AS-treated mice showed larger scars with thinner LV walls and significantly depressed cardiac contractility, indicating that, by interfering with multiple cellular events, the inhibitor detrimentally impinges on cardiac recovery.
To gain further insight into the relevance of PI3K␥ in reparative angiogenesis, we investigated the response of PI3K␥ KD and KO mice to MI. The results obtained in genetically modified animals overall confirm an important role of PI3K␥ in reparative neovascularization and healing of MI. Nonetheless, some intriguing differences were uncovered, with KO animals showing more remarkable activation of EC and cardiomyocyte apoptosis and inhibition of EC proliferation as compared to KD. This translated into larger scars and more profoundly compromised LV function in KO animals. These data are in line with susceptibility of PI3K␥ KO mice to cardiac damage, which was attributed to elevation of cAMP in KO hearts. 9 Increased myocardial cAMP in settings of acute MI is detrimental, causing perfusioncontraction mismatching, increased myocardial energetic requirements, and an unfavorable flow redistribution away from the ischemic subendocardium. 43 In KD mice, reparative angiogenesis was less severely impaired compared to KO, although MI-induced cardiac dysfunction was similar to WT controls. Our genetic models show that, in reparative angiogenesis, the absence of PI3K␥ protein is more detrimental than the inactivation of its catalytic activity. This is in agreement with previous reports, 7 but is in apparent contrast with our pharmacological studies. One caveat of our pharmacological approach is that some of the effects induced by AS might be attributable to partial inhibition of other PI3K isoforms (ie, PI3K␣), which is unlikely at the elected dosage, or to interference with unrelated enzymes. In human ECs, we have shown that AS specifically suppresses Akt phosphorylation induced by adenovirusmediated PI3K␥ overexpression, while not inhibiting VEGFinduced Akt activation. Furthermore, both AS and PI3K␥ silencing inhibit angiogenesis in vitro, with no additional effect when AS is superimposed to PI3K␥ silencing. Although we cannot completely exclude that the AS compound is not selective enough to uniquely block PI3K␥ function in vivo, it is conceivable that the milder phenotype of infarcted KD mice compared AS-treated mice may be attributable to the development of compensatory/adaptive mechanisms in the genetically modified mice. 44 Taken together, our findings clearly establish PI3K␥ as a key player in physiological and reparative angiogenesis, as well as healing of MI. Additionally, our results point out the and cardiomyocytes (B, iv) was also evaluated in PI zone of WT, KD, and KO hearts. nϭ4 for each group. C, HL-1 were serum starved and exposed to hypoxia (0.2% O 2 , 5% CO 2 ) in the presence of DMSO or AS for 18 hours. Bar graph shows caspase-3/7 activity assessed as in Figure 1D ; nϭ3. *PϽ0.05, **PϽ0.01, ***PϽ0.001 vs DMSO or WT; #PϽ0.05, ###PϽ0.001 vs KD.
need for new chemical structures with improved selectivity profiles and devoid of the harmful effects shown by AS.
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Novelty and Significance
Phosphoinositide-3 kinase (PI3K)␥ is a pivotal mediator of leukocytes chemotaxis. Given the participation of inflammatory cells in reparative and pathological angiogenesis, PI3K␥ has become a hot topic for vascular and cancer researchers and pharmaceutical industry, which claims PI3K␥ inhibitors to be "the aspirin of the new millennium." We and others concurrently reported that knockout of PI3K␥ impairs endothelial progenitor cells functions and homing to site of ischemic injury, thus alerting against the risk of PI3K␥ signaling perturbation. We now show that pharmacological targeting of PI3K␥ inhibits angiogenesis in a model of myocardial infarction, leading to enhanced apoptosis in the peri-infarct zone, enlarged scars and increased cardiac dysfunction. Akt-dependent signaling, which regulates migration and survival of endothelial cells, is remarkably hampered following PI3K␥ inhibition. We then verified whether genetically modified mice lacking PI3K␥ or carrying a kinase-dead mutation are phenocopies of mice treated with PI3K␥ inhibitor. Interestingly, knockout mice showed severely impaired reparative angiogenesis and large infarcts, whereas kinase-dead mice failed to mount a proper neovascularization, but showed no additional cardiac dysfunction compared to controls. These results reveal an unexpected complex contribution of PI3K␥ to vascular and cardiac repair processes and call for caution in the use of first-generation PI3K␥ inhibitors in myocardial ischemia.
What Is Known?
• PI3K␥, a kinase that links G protein-coupled receptors to the Akt pathway, plays a key role in inflammation by acting as a compass for the directional migration of leukocytes.
• Pharmacological inhibitors of PI3K␥ may be useful as antiinflammatory agents.
• Genetic disruption of PI3K␥ impairs neovascularization and integrindependent homing of endothelial progenitor cells in a model of peripheral ischemia.
What New Information Does This Article Contribute?
• PI3K␥ plays a major role in reparative angiogenesis in a model of myocardial infarction.
• Pharmacological inhibition of PI3K␥ to fight inflammation may jeopardize the ischemic heart.
1
SUPPLEMENT MATERIAL Detailed Methods
Cell Cultures
Human umbilical vein endothelial cells (HUVEC, Cambrex) were cultured in EGM-2 (EBM-2 plus with EGM-2 SingleQuots of growth supplements) containing 2% fetal bovine serum (FBS) (complete medium) and used between passages 3 and 6. HL-1 cells (immortalized adult mouse cardiomyocytes, kind gift of Prof Claycomb, Louisiana State University, New Orleans, USA) 1 were grown in Claycomb medium (Sigma-Aldrich) supplemented with 0.1 mM norepinephrin, 2 mM Lglutamine and 10% FBS. In all in vitro experiments, culture media were supplemented with 1µM AS605340 (AS, Sigma-Aldrich), 15µM LY294002 (LY, Calbiochem) in dimethyl sulfoxide (DMSO, Sigma-Aldrich) or an equal volume of DMSO alone. 2 Isolation of primary monocytes and lymphocytes. Myocardial infarction was induced in CD1 mice (vide infra). Two d after MI induction, peripheral blood mononuclear cells (PB-MNCs) were obtained by standard methods (HISTOPAQUE-1083, Sigma-Aldrich) from whole peripheral blood collected directly from the heart. PB-MNCs were plated in six-well tissue culture plates and allowed to adhere for 2 h at 37°C in a humidified atmosphere containing 5% CO 2 , in order to obtain monocytes, as described. 3 The non-adherent cells (lymphocytes) were then transferred to fresh tissue culture flasks. Treatments and immunoblot analyses were performed the day after isolation.
Isolation of bone marrow mononuclear cells (BM-MNCs) and cell migration assay:
BMMNCs were obtained from the femurs of the mice used for primary leukocytes isolation, as described 4 and incubated for 30 min with DMSO or AS (1 µM) in RPMI containing 0.1% BSA. The pre-treated cells (1x10 5 cells/well) were added to the upper chamber of a 24-well chemotaxis chamber (Transwell, Costar. Filters pore size: 3 µm). The lower chamber was loaded with RPMI containing 0.1% BSA and 5% FBS plus DMSO or AS. After 18 hours incubation at 37°C, nonmigrating cells were removed from the upper side of the filter and migrated cells were collected and counted in neubauer chamber.
Recombinant adenoviral vectors and infection of HUVEC. In order to generate a recombinant adenoviral vector carrying the human Pikcg gene (Ad.PI3K), the coding sequence was digested from a pcDNA3 vector with XbaI and BamH1 (New England Biolabs). Fragments were subsequently ligated into the adenovirus shuttle vector pDC515 (Microbix Biosystems). Replication deficient adenoviruses were generated by site-specific FLP-mediated recombination of the co-transfected shuttle and genomic plasmids in 293 cells. Ad.Null describes control virus. The recombinant adenoviral vector targeting PI3K catalytic subunit, p110, (Ad.siRNA) and the relevant scrambled siRNA adenovirus (Ad.scrambled) were kindly provided by Prof. Patrick E. MacDonald and Dr. Jocelyn Manning Fox, University of Alberta, Canada. Both constructs (which co-expressed GFP) were described previously, 5 and were expanded in HEK293 cells. Infection efficiency was 100% as confirmed by GFP expression. About 75% knockdown was achieved after 3 d. The adenovirus expressing myristoylated Akt (Ad.MyrAkt, HA tagged), a constitutively active mutant form of Akt, was previously described 6 . Ad.Null (empty vector, Ad-rad66) was used as control. HUVEC were grown in complete medium in 6-well plates till 55-60% confluent and were then infected overnight with the different adenoviral vectors at 100 multiplicity of infection (MOI). Then medium was changed and cells were used 2 d (Ad.MyrAkt/Ad.Null) or 3 d (Ad.PI3K/Ad.Null and Ad.siRNA/Ad.scrambled) after infection.
Functional Assays on HUVEC
Cell proliferation. HUVEC (5x10 3 cells/well) were seeded in 96-well plates until adherent and then incubated for 20 h at 37°C, 5% CO 2 in complete medium containing DMSO, AS or LY in the presence of BrdU. BrdU incorporation was detected using the Cell Proliferation ELISA, BrdU colorimetric kit (Roche) according to the manufacturer's instruction. Five replicates of each condition were performed in each of three separate experiments.
Scratch assay. HUVEC were grown to a confluent monolayer in 48-well plates and then scratched with a p1000 pipette tip. After removal of debris by washing, each well was photographed using an inverted microscope (Axiovert 200 connected to AxioCam MRC, ZEISS). Cells were then incubated for 24 h at 37°C, 5% CO 2 in complete medium containing 2mM hydroxyurea (Sigma) to induce growth arrest in the presence of the PI3K inhibitors or DMSO. Cells were finally fixed with 2% paraformaldehyde (PFA) and photographed. The distance between migrating fronts was measured using the Image-Pro Plus software (Media Cybernetics), as previously described. 7 Each condition was run in quadruplicate and the assay was repeated three times.
In vitro angiogenesis assay. HUVEC were pre-treated for 10 min with PI3K inhibitors or DMSO and were then seeded in 48-well plates at 4x10 4 cells/well on top of 150μl gelified Matrigel (BD Biosciences) containing DMSO, AS or LY and incubated overnight at 37°C, 5% CO 2 . Floating cells were removed by washing and the endothelial networks were fixed with 2% PFA. Number of branches and total length of the networks were calculated using the Image-Pro Plus software on images taken at 50X magnification. Each condition was run in triplicate and the assay was repeated three times.
Apoptosis assay. HUVEC (5x10 3 /well) and HL-1 (5x10 3 /well) were seeded in flat bottomed 96-well plates and incubated at 37°C, 5% CO 2 , overnight to allow adhesion. On the following day, HL-1 cells were serum starved (0% FBS) for 8 h before treatment with DMSO or AS and exposure to hypoxia. Hypoxia (0.2% O 2 , 5% CO 2 ) was created with the aid of a 95% N 2 /5% CO 2 gas mixture (Air Liquide, Paris, France) introduced under the control of the PROOX sensor (model 110; BioSpherix, Redfield, NY) in an automated PROOX in vitro chamber (C-174; BioSpherix). Serum starved HUVEC (0.2% FBS in EBM-2) and HL-1 (0% FBS in Claycomb medium) treated with DMSO, AS or LY were incubated in hypoxic conditions for 18 h in a humidified incubator at 37°C. Cells were then immediately assessed for Caspase-3/7 activity by using a luminescent cell death detection kit (Caspase-Glo 3/7 Assay, Promega), according to the instruction of the manufacturer. Three independent experiments with four replicates each were performed.
All functional assays were performed also on Ad.siRNA/Ad.scrambled HUVEC with or without AS or LY as indicated.
Animal Procedures
Induction of myocardial infarction and echocardiography. Myocardial infarction (MI) was induced by permanent ligation of left anterior descending artery (LAD) in 9 weeks old CD1 mice or 12-14 weeks old inbred WT, KD and KO mice (C57Bl/6 background) as described earlier. 8 In brief, under anesthesia (2,2,2 tribromo ethanol, 0.3gm/kg, IP, Sigma-Aldrich) and artificial ventilation, chest cavity was opened and after carefully dissecting the pericardium, LAD was permanently ligated using a 7-0 silk suture (Ethicon). Animals were recovered with aseptic precautions and all animals received analgesic (Buprenorphine, 0.05-0.1 mg/kg/subcutaeously) to reduce postoperative pain. Sham operated animals underwent a similar procedure without ligation of the suture.
Before and on day 14 after MI, hearts were imaged in the 2-dimensional parasternal shortaxis view, and an M-mode measurement was recorded at the mid-ventricle, at the level of the papillary muscles. Heart rate, thickness of left ventricular (LV) walls, end-diastolic and end-systolic diameters and volumes were measured from the M-mode image. Stroke volume was defined as end-diastolic minus end-systolic volume. Fractional shortening and ejection fraction were used as indexes of contractility. Cardiac output was calculated multiplying stroke volume by heart rate.
Ventricles from hearts arrested in diastole by intraventricular injection of cadmium chloride (100 nmol) were perfusion/fixed and harvested for histological analyses 3 and 14 d after surgery and were dissected at apical, mid-ventricular, and basal level and then fixed with 4% buffered formalin for 24 h at RT. Subsequently, samples were kept in PBS for 24 h at 4°C and then processed for paraffin-embedding. Paraffin sections were cut at 3 or 5 µm thickness for following histological analyses.
For immunoblot analysis, left and right ventricles were set apart and immediately frozen in liquid nitrogen. 568 (both Invitrogen) for 1 h at RT. Nuclei were visualized by DAPI (4',6-diamidino-2-phenylindole, Sigma-Aldrich) staining. Slides were mounted with Fluoromount-G mounting medium (SouthernBiotech). Images were captured at 500X magnification using an Olympus BX40 fluorescence microscope. Capillary and arteriole densities were evaluated in remote (R) and PI zone of heart sections from the mid-ventricular area of AS-or DMSO-treated and WT, KD and KO infarcted hearts 14 d post-MI (n=4 to 8 hearts per group). Arterioles (recognized as double positive for Lectin IB 4 and α-SMA) were subdivided into 3 groups according to their luminal diameter: between 10 and 20 µm, 20 and 50 µm, and bigger than 50 µm diameter. Densities were expressed as number of capillaries/arterioles per square millimeter of tissue analyzed.
Proliferating ECs were counted in PI zone of heart sections from the mid-ventricular area of AS-or DMSO-treated and WT, KD and KO infarcted hearts 3 d post-MI (n=4 AS-treated; n=6 DMSO-treated; n=4 each group of transgenic mice). Sections were stained with a mouse monoclonal anti-PCNA antibody (Proliferating Cell Nuclear Antigen, clone PC10, Dako) and biotinconjugated isolectin IB 4 followed by goat anti-mouse Alexa Fluor 488 and Stp-Alexa Fluor 568. Nuclei were visualized by DAPI.
To quantify apoptotic ECs and cardiomyocytes, sections consecutive to those used for analysis of EC proliferation were screened. Apoptotic cells were recognized as positive to TUNEL reaction (In Situ Cell Death Detection Kit, TMR red, Roche), carried out according to the manufacturer's instruction. ECs were stained as described above, with the only difference of using Stp-Alexa Fluor 488 for visualization. Nuclei of cardiomyocytes were considered those positioned in the center of cardiac myocytes.
The percentages of both proliferating and apoptotic cells were calculated dividing the number of positive nuclei by the total number of nuclei of the same cell type, and multiplying by 100.
Morphometric Evaluation of Infarct Size
Hearts (n=8 AS-treated; n=6 DMSO-treated; n=9 WT; n=7 KD; n=6 KO) 14 d post-MI were used for infarct size measurement. Sections (5 μm thick) from three levels of each heart (apical, mid-ventricular, and basal) were stained by Azan Mallory staining. All histological sections were examined with an Olympus BX40 microscope at 12.5X magnification. Images were captured and analyzed using the Image-Pro Plus software. Infarct size was measured as described elsewhere. 10 Briefly, both infarct length and LV circumference were drawn at the center between the epicardial and endocardial surfaces. Percent infarct size was calculated by dividing the sum of midline infarct lengths from all sections by the sum of midline circumferences from all sections and multiplying by 100.
Online Figure I . AS605240 inhibits the PI3K/Akt pathway in HUVEC selectively and in a dose-dependent manner. A, HUVEC were incubated in EC basal medium with neither growth factors nor serum for 3 h. During the last 30 min before stimulation, cells were pre-treated with DMSO (0) or increasing concentrations of AS up to 10 µM, followed by 10 min stimulation with complete medium containing growth factors and serum. Immunoblot analysis shows the dosedependent inhibition of the Akt signaling pathway. In accordance with previous reports, 2, 11 the concentration of 1 µM was used for further experiments, in order to avoid off-target activities. B, HUVEC were transduced with 100 MOI of Ad.Null or Ad.PI3K overnight. Three days after gene transfer, cells were incubated in EC basal medium for 3 h as above and pre-incubated for 30 min before stimulation with DMSO (0) or AS at 1 or 10 µM, followed by 10 min stimulation with complete medium containing growth factors and serum. Protein extracts were analyzed in immunoblot for the expression of PI3K and activation of Akt. C, Immunoblot analysis of VEGFstimulated activation of the Akt pathway in cells treated with AS (1 µM) or DMSO indicate the lack of inhibitory activity of AS on class IA PI3Ks. n=3 for each experiment. A and B, Monocytes and T lymphocytes were isolated from the peripheral blood of mice 2 d after MI induction as described in the Detailed Methods section. Cells were serum-starved for 2 h, followed by 30 min incubation with DMSO or AS (1 µM) in starvation medium. Cells were then serum stimulated for 10 min and immediately collected for immunoblot analysis. Protein extracts were analyzed for the expression of PI3K and phosphorylation levels of Akt and GSK3β. Blot images show the striking downmodulation of the Akt pathway following PI3K inhibition in both cell types. n=3 for each cell type. C, MNCs from the bone marrow of the same infarcted mice were isolated, incubated with DMSO or AS (1 µM) for 30 min and then allowed to migrate overnight towards 5% FBS (transwell migration assay). n=3. * P<0.05 vs. DMSO.
